检索结果 - C. D. Imbusch

P548: BEMCENTINIB COMBINED WITH LOW-DOSE CYTARABINE IS EFFICACIOUS AND WELL TOLERATED IN RELAPSED AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY. UPDATES FROM THE ONGOING PHASE II T... 由 S. Loges, M. Heuser, J. Chromik, G. Sutamtewagul, S. Kapp-Schwoerer, M. Crugnola, N. Di Renzo, R. Lemoli, D. Mattei, I. Ben-Batalla, J. Waizenegger, L.-M. Rieckmann, M. Janning, C. D. Imbusch, N. Beumer, D. Micklem, C. Gorcea-Carson, G. Lawson, J. Nautiyal, S. Deharo, W. Fiedler, Y. Alvarado-Valero, B. Gjertsen

获取全文